Cite
HARVARD Citation
Xie, J. et al. (2021). Characteristics and treatment patterns of relapsed/refractory diffuse large B-cell lymphoma in patients receiving ≥3 therapy lines in post-CAR-T era. Current medical research and opinion. pp. 1789-1798. [Online].